NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
08/13/2023
Back to search
Official data from USPTO
DRAQ7
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
08/13/2023
Trademark type
Word
Nice classes
1, 5
Filing date
05/21/2013
Registration date
12/31/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/12/2023
Last transaction
08/12/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
04/26/2010
First use in commerce
04/26/2010
Drawing code
4
Owner type
11
Owner location
Leicestershire, GB
Examiner
CHISOLM, KEVON
Law office
L30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Biostatus Limited
Representatives
Nicole M. Meyer Dickinson Wright PLLC
Technical classification
Nice Classes
Class 1Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Diagnostic scanning agents for in-vitro useassays and reagents for use in cell-based scientific research; chemical preparations for use as fluorescent substrates in imaging of cells in cell-based scientific research; fluorescent chemical preparations for use in imaging in cell-based scientific research; substances for use in genetic probe assay kits for scientific or research usebiochemical agentscommonly known as probesfor detecting and analyzing cells in cell-based research
Class 5
Diagnostic agents for in-vitro use to locate cancer sites and for clinical and medical laboratory use; biological preparations for use as diagnostic agents for the diagnosis of diseases; diagnostic scanning agents for in-vitro usemarkers for therapeutic or diagnostic use; fluorescent light emitting reagents for fluorescence-based detection systems for medical or clinical use; substances for use in genetic probe assay kits for medical usebiochemical agentscommonly known as probesfor detecting and analyzing cells in cell-based research; chemical preparations for use in DNA analysis for medical purposes
Publications
History of USPTO decisions and trademark events.
21 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
08/12/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
08/12/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/12/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
01/27/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
12/31/2022
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/25/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/25/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/25/2020
E815
TEAS SECTION 8 & 15 RECEIVED
12/30/2019
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
12/31/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/06/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2013
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/15/2013
PUBO
PUBLISHED FOR OPPOSITION
10/15/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/25/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/07/2013
DOCK
ASSIGNED TO EXAMINER
09/07/2013
MPMK
NOTICE OF PSEUDO MARK E-MAILED
06/04/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/01/2013
NWAP
NEW APPLICATION ENTERED
05/24/2013
Continuous trademark protection
Get notified about every new filing that threatens DRAQ7 or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.